Bentham Science is a science, technology, and medical publisher,
providing academic researchers and industrial professionals with
the latest information in diverse fields of science and technology.
Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books (under the Bentham Books brand) have an ever-increasing readership of millions of researchers worldwide.
Bentham Science was originally incorporated in the Netherlands. We are now a multinational company based in UAE and have employees in the USA, the Netherlands, Spain, India, and China. Bentham Science also outsources its publishing services to several countries, including the UK, China, and Pakistan.
Bentham Science currently publishes more than 130 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies, information of our journals' indexation by various indexing agencies can be viewed. at https://benthamscience.com/indexing-agencies
66 Bentham Science journals have received impact factor rankings in the annual Journal Citation Report 2023. For more information, click here: https://www.benthamscience.com/press-release-detail/181
Bentham Science follows the single blind peer-review procedure for submissions of all manuscripts to its journals, except for a selected number of patent journals where double blind review is followed.
All submitted articles/eBook chapters are subjected to an extensive peer review in consultation with members of the journal's editorial board and independent external reviewers (usually three reviewers). All manuscripts/chapters are assessed and the decision is taken by the journal's Editor-in-Chief/eBook Editor keeping in view all the peer reviewers' comments. The final decision is then conveyed to the author(s).
Since reviewers play an essential role in maintaining the integrity and accuracy of the research, therefore to acknowledge their role, Bentham Science has made its publications and review information available on Publons. Publons provides a formal recognition to our peer reviewers by displaying a verified record of their peer review and editorial contributions for academic journals on their website. For more information, click here: https://publons.com/publisher/219/bentham-science-publishers
In addition to the wide range of scientific journals, Bentham Science has a book publishing program (Bentham Books) which publishes works on diverse topics. Our book catalog features more than 1000 titles, with multiple titles published annually. We continue to broaden our publishing scope by expanding our books and journals catalog annually, to also include works relevant to established and emerging disciplines. Learn more about Bentham Books here: https://benthambooks.com/.
Bentham Science offers a reliable publishing experience to authors from the initial manuscript submission till the final publication, through our state of the art journal management system which makes the publication process smooth and timely. With a productive association of 10,000 eminent scientists on the editorial boards, (including Nobel laureates as honorary advisors), Bentham Science provides high-quality peer review services to maintain their standards in publication.
In addition to publication opportunities for researchers, we also offer scholarly content licensing solutions, through our online store Eureka Select, to academic and corporate libraries interested in our journals and books. The online store also make our publications available for individual readers and publishers. Visit the online store, Eureka Select, here:EurekaSelect
Bentham Science is always open to new ideas and partnerships. If you are a researcher, librarian or distributor, and wish to work with us, please contact us at info@benthamscience.net.
"Current Medicinal Chemistry is a frontier review journal, which contains comprehensive reviews written by leading scientists in their respective fields. The journal presents the latest developments in various areas of medicinal chemistry. I strongly recommend it to scientists working in the field."
"Current Genomics represents a frontier review journal, which contains comprehensive reviews written by leading scientists in the respective fields. This journal presents the latest developments in the area of genomics. This is strongly recommended."
"The 4 new journals Recent Patents on Anti-Cancer Drug Discovery, Recent Patents on Cardiovascular Drug Discovery, Recent Patents on CNS Drug Discovery, Recent Patents on Anti-Infective Drug Discovery are important patents journals in the field of Anti-Cancer Drug Discovery, Cardiovascular Drug Discovery, CNS Drug Discovery and Anti-Infective Drug Discovery, which should provide research scientists in the fields with recent developments in various frontier areas. These journals are strongly recommended to the scientific community".
Max-Planck-Institut für Biochemie Martinsried, Martinsried, Germany
"In view of the growing volume of literature, the role of a high quality review journal has become increasingly important. Current Medicinal Chemistry presents expert overviews in the field of medicinal chemistry of general interest to the scientific community."
"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."
"Mini-Reviews in Medicinal Chemistry represents an important review journal of great value to pharmaceutical scientists."
"Current Topics in Medicinal Chemistry is recommended as a forum for the publication and review of important aspects of medicinal chemistry including the design and synthesis of compound libraries for bioactivity testing."
Université Louis Pasteur Strasbourg, France
"Current Medicinal Chemistry is a frontier review journal, which contains comprehensive reviews written by leading scientists in their respective fields. The journal presents the latest developments in various areas of medicinal chemistry. I strongly recommend it to scientists working in the field."
"Current Genomics represents a frontier review journal, which contains comprehensive reviews written by leading scientists in the respective fields. This journal presents the latest developments in the area of genomics. This is strongly recommended."
"The 4 new journals Recent Patents on Anti-Cancer Drug Discovery, Recent Patents on Cardiovascular Drug Discovery, Recent Patents on CNS Drug Discovery, Recent Patents on Anti-Infective Drug Discovery are important patents journals in the field of Anti-Cancer Drug Discovery, Cardiovascular Drug Discovery, CNS Drug Discovery and Anti-Infective Drug Discovery, which should provide research scientists in the fields with recent developments in various frontier areas. These journals are strongly recommended to the scientific community".
Max-Planck-Institut für Biochemie Martinsried, Martinsried, Germany
Bentham Science is a world-leading science, technology, and medical publisher. Our peer-reviewed journals and books serve as a beacon for millions of researchers and professionals worldwide. From pharmaceutical research to technology, we provide the latest insights across diverse fields.
Read more
Originally founded in the Netherlands, Bentham Science has evolved into a multinational powerhouse headquartered in the UAE. With dedicated teams in the USA, the Netherlands, Spain, India, China, and outsourced services in the UK, China, and Pakistan, we ensure that knowledge knows no borders.
Read more
We publish over 130 journals in electronic and print formats, spanning pharmaceutical research, medical specialties, engineering, technology, and social sciences. Our indexed journals ensure your research reaches the right audience.
Read more